Searched for
GSK VACCINES
GSK set to get $500 million from settlement of mRNA lawsuitCureVac NV has settled its US patent dispute with Pfizer and BioNTech SE regarding mRNA vaccines, resulting in GSK receiving up to $500 mil...
Bharat Biotech, GSK to halve price of malaria vaccine by 2028Drugmakers Bharat Biotech and GSK will reduce the price of their malaria vaccine, Mosquirix, to $5 per dose by 2028, more than halving the ...
GSK launches $2.5 bln buyback, lifts sales target after stellar Q4GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, bett...
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technologyGlaxoSmithKline (GSK) has filed a lawsuit against Pfizer and BioNTech in Delaware federal court, alleging infringement of GSK's patents rel...
Sanofi, GSK variant-specific Covid-19 shot found effective against Omicron"Sanofi-GSK's vaccine is the first candidate to demonstrate efficacy in a placebo-controlled trial in an environment of high Omicron varian...
GSK's RSV vaccine succeeds in late-stage trial for older adultsThe RSV vaccine is a key component of the British drugmaker's plans to boost its drug development success rate as it prepares to spin off i...
GSK transfers malaria vaccine production to India's Bharat BiotechThe agreement includes transfer of manufacturing of the protein part of the vaccine, RTS,S/AS01, while GSK will continue to supply Bharat B...
GSK, Sanofi say COVID-19 shot won't be ready until late 2021The companies said early trials showed the vaccine produced an "insufficient" immune response in older adults, demonstrating the need to re...
GSK, Sanofi to make 200 mn doses available for COVID-19 vaccine allianceCOVAX aims to deliver 2 billion vaccine doses around the world by the end of 2021, and more than 180 nations have joined the plan. The Unit...
GSK will price vaccine responsibly: Emmanuel Hanon, R&D HeadGSK said it was not expecting to profit from its collaborations on a vaccine candidate during the pandemic as the company rushes to offer 1...
GSK, Sanofi team up to bring out Covid-19 vaccineTwo of the world's largest vaccine manufacturers, Sanofi and GlaxoSmithKline, are coming together to work on a Covid-19 vaccine, which if i...
GSK's tuberculosis vaccine shows promising resultsThe new vaccine, known as M72/AS01E, was tested at 11 sites in Kenya, South Africa and Zambia in adults whose blood tests showed they had l...
GSK Pharma trying to find out what ammunition is needed to grow: MDThe Indian arm of British drugmaker GlaxoSmithKline (GSK) is planning a major initiative to wrestle back ground it had conceded.
GSK Pharma completes deal with Novartis HealthcareDrug firm GlaxoSmithKline Pharmaceuticals has acquired Novartis' vaccines business and divested its marketed oncology portfolio to Novartis...
Competition Commission of India clears Novartis-GlaxoSmithKline pharma dealThe multi-layered deal involves UK-based GlaxoSmithKline acquiring Novartis's vaccine biz, while latter would purchase GSK's cancer drugs p...
Experimental Ebola vaccine appears safe in human trialsThe Ebola virus genetic material is delivered by a carrier virus (chimpanzee-derived adenovirus 3 or cAd 3) that causes a common cold in ch...
Novartis buys GSK's cancer drugs for $14.5 billion in a 3-way dealThe collaboration between the two will create a new world-leading consumer healthcare business with $10 billion in annual sales.
- GSK in 50:50 JV with Biological E for developing paediatric vaccine
The vaccine would enable fewer injections for children thereby improving compliance in immunisation schedules.
- Govt lets GSK test H1N1 vaccine
The government has decided to let Anglo-American drug maker GlaxoSmithKline (GSK) to do ‘quick’ experiments of its swine flu vaccine on Ind...
- GlaxoSmithKline wins European nod for bird flu vaccines
British pharmaceuticals giant GlaxoSmithKline has won European recommendations for two vaccines aimed at combatting a potential bird flu pa...